Literature DB >> 2295704

Regulation of the anti-Sm autoantibody response in systemic lupus erythematosus mice by monoclonal anti-Sm antibodies.

R A Eisenberg1, D S Pisetsky, S Y Craven, J P Grudier, M A O'Donnell, P L Cohen.   

Abstract

The administration of certain monoclonal anti-Sm antibodies (2G7, 7.13) induced most MRL/lpr mice to become anti-Sm positive by 5 mo of age, although other anti-Sm monoclonals (Y2, Y12) suppressed the spontaneous response. Positive anti-Sm antibody enhancement occurred efficiently only in MRL/lpr mice and not in other systemic lupus erythematosus mice that have little spontaneous anti-Sm production. The enhancement by anti-Sm antibodies was specific for the anti-Sm response. The mechanism of the passive antibody enhancement was apparently not isotype- or idiotype-related. The fine specificity of the anti-Sm monoclonal antibody may be essential to its enhancing or suppressing effects, since both enhancing monoclonals recognized only the D Sm polypeptide, whereas both suppressing monoclonals saw the D and the B polypeptides. Furthermore, analysis of serial bleeds from unmanipulated MRL mice that developed anti-Sm positivity showed that the D specificity almost always appeared first. We hypothesize, therefore, that those animals in which an anti-Sm response is initiated by D-specific B-cell clones can become serologically positive with the aid of a positive feedback loop. In contrast, animals in which the initial specificity is for both B and D peptides would be prevented from developing a full anti-Sm response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295704      PMCID: PMC296390          DOI: 10.1172/JCI114437

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Quantitation and IgG subclass distribution of antichromatin autoantibodies in SLE mice.

Authors:  C L Fisher; R A Eisenberg; P L Cohen
Journal:  Clin Immunol Immunopathol       Date:  1988-02

2.  Sequential development of antibodies to specific Sm polypeptides in a patient with systemic lupus erythematosus: evidence for independent regulation of anti-double-stranded DNA and anti-Sm antibody production.

Authors:  E J ter Borg; G Horst; E Hummel; D Jaarsma; P C Limburg; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1988-12

3.  Differential induction of lupus associated antinuclear antibodies in MRL mice by monoclonal anti-Sm antibodies.

Authors:  M R Stocks; D G Williams; R N Maini
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

4.  Anti-Sm autoantibodies in MRL mice: analysis of precursor frequency.

Authors:  P L Cohen; E W Shores; R Rapoport; S Caster; R A Eisenberg; D S Pisetsky
Journal:  Cell Immunol       Date:  1985-12       Impact factor: 4.868

5.  The polypeptide structure of the Sm and RNP nuclear antigens.

Authors:  R A Eisenberg; D G Klapper; P L Cohen
Journal:  Mol Immunol       Date:  1983-02       Impact factor: 4.407

6.  Subclass restriction of anti-Sm antibodies in MRL mice.

Authors:  R A Eisenberg; J B Winfield; P L Cohen
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

7.  Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.

Authors:  R A Eisenberg; S Y Craven; R W Warren; P L Cohen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

8.  The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies.

Authors:  I Pettersson; M Hinterberger; T Mimori; E Gottlieb; J A Steitz
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

Review 9.  Control of isotype expression by helper T-cell clones and suppressor cells.

Authors:  J Thèze; I Löwy; M Seman; C Brézin; C Neauport-Sautes; W H Fridman
Journal:  Ann Immunol (Paris)       Date:  1983 Jul-Aug

10.  Influence of assay conditions on ELISA determinations of anti-DNA antibodies.

Authors:  D S Pisetsky; K F Semper
Journal:  J Immunol Methods       Date:  1984-11-30       Impact factor: 2.303

View more
  9 in total

Review 1.  Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity.

Authors:  R A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Lessons about autoantibody specificity in systemic lupus erythematosus from animal models.

Authors:  D I Stott
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

Review 3.  Regulation of autoreactive anti-IgG (rheumatoid factor) B cells in normal and autoimmune mice.

Authors:  H Wang; M J Schlomchik
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  Further characterization of the autoantibody response of Palmerston North mice.

Authors:  B S Handwerger; C E Storrer; C S Wasson; F Movafagh; M Reichlin
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

Review 5.  Features of autoantigens.

Authors:  W H Reeves; M Satoh
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

Review 6.  Mechanisms of autoimmunity.

Authors:  Robert Eisenberg
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy.

Authors:  J Cohen; R Bakimer; M Blank; G Valesini; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

8.  Pathogenic serum IgG anticardiolipin antibodies and the idiotypic network.

Authors:  J Cohen; R Bakimer; M Blank; G Valesini; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

9.  RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

Authors:  Christina M Lau; Courtney Broughton; Abigail S Tabor; Shizuo Akira; Richard A Flavell; Mark J Mamula; Sean R Christensen; Mark J Shlomchik; Gregory A Viglianti; Ian R Rifkin; Ann Marshak-Rothstein
Journal:  J Exp Med       Date:  2005-10-31       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.